Generate a comprehensive and actionable clinical summary paragraph for Patient 9bf4f83a-ead6-98e6-cb4c-36d83845d998 Schuster709 Humberto482 male 1973-10-25 828 Lebsack Crossroad Apt 17 Anderson OH 00000. Summarize in a one A4 page length report patient's medical history, treatment course, and include relevant clinical information, advice, and a clear course of action. Ensure the summary is concise yet informative, enabling doctors to effectively engage with the patient and guide their ongoing care given this data information: Condition Medication review due (situation) Diagnosis Report History and physical note 1973-10-25 17:51:25+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1974-01-31 18:51:25+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1974-04-04 17:51:25+10:00 Diagnosis Report History and physical note 1974-05-31 15:51:25+10:00 Diagnosis Report History and physical note 1974-06-18 06:51:25+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1974-07-04 17:51:25+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1975-01-02 18:51:25+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1975-04-03 17:51:25+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1976-04-01 17:51:25+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1977-09-29 17:51:25+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1978-03-02 18:51:25+11:00 Diagnosis Report History and physical note 1978-10-19 17:51:25+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1980-10-16 17:51:25+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1981-10-22 17:51:25+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1983-11-03 18:51:25+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1985-12-26 18:51:25+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1986-11-20 18:51:25+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1987-11-26 18:51:25+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1990-12-13 18:51:25+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1991-09-12 17:51:25+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1991-09-19 17:51:25+10:00 Condition Received higher education (finding) Diagnosis Report History and physical note 1991-12-19 18:51:25+11:00 Condition Has a criminal record (finding) Diagnosis Report History and physical note 1992-12-24 18:51:25+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 2000-01-20 18:51:25+11:00 Condition Part-time employment (finding) Diagnosis Report History and physical note 2002-01-03 18:51:25+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 2003-08-14 17:51:25+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 2005-01-06 18:51:25+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 2008-01-10 18:51:25+11:00 Condition Stress (finding) Diagnosis Report History and physical note 2011-01-13 18:51:25+11:00 Diagnosis Report History and physical note 2012-03-13 13:51:25+11:00 Condition Full-time employment (finding) Diagnosis Report History and physical note 2012-03-22 18:51:25+11:00 Diagnosis Report History and physical note 2013-09-26 09:51:25+10:00 Diagnosis Report History and physical note 2013-10-14 05:29:24+11:00 Condition Body mass index 30+ - obesity (finding) Condition Limited social contact (finding) Observation final Body Height 180.4 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} Observation final Body Weight 97.9 kg Observation final Body mass index (BMI) [Ratio] 30.07 kg/m2 Observation final Blood pressure panel with all children optional 84 mm[Hg] 125 mm[Hg] Observation final Heart rate 96 /min Observation final Respiratory rate 12 /min Observation final Leukocytes [#/volume] in Blood by Automated count 4.2716 10*3/uL Observation final Erythrocytes [#/volume] in Blood by Automated count 3.9935 10*6/uL Observation final Hemoglobin [Mass/volume] in Blood 16.998 g/dL Observation final Hematocrit [Volume Fraction] of Blood by Automated count 49.945 % Observation final MCV [Entitic volume] by Automated count 86.127 fL Observation final MCH [Entitic mass] by Automated count 28.361 pg Observation final MCHC [Mass/volume] by Automated count 35.279 g/dL Observation final Erythrocyte distribution width [Entitic volume] by Automated count 45.539 fL Observation final Platelets [#/volume] in Blood by Automated count 322.25 10*3/uL Observation final Platelet distribution width [Entitic volume] in Blood by Automated count 511.13 fL Observation final Platelet mean volume [Entitic volume] in Blood by Automated count 9.9541 fL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2013-10-31T18:51:25+11:00 Immunization completed Hep A, adult 2013-10-31T18:51:25+11:00 Diagnosis Report CBC panel - Blood by Automated count 2013-10-31 18:51:25+11:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2013-10-31 20:04:18+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2013-10-31 20:45:35+11:00 Diagnosis Report History and physical note 2013-10-31 18:51:25+11:00 Condition Chronic pain (finding) Condition Chronic low back pain (finding) Condition Chronic neck pain (finding) Observation final Pain intensity, Enjoyment of life, General activity (PEG) 3 item pain scale 3.6612 {score} 3.817 {score} 2.137 {score} Observation final Drugs of abuse 5 panel - Urine by Screen method Diagnosis Report History and physical note 2014-02-01 18:51:25+11:00 Observation final Pain severity - Reported 6.1537 {score} Diagnosis Report History and physical note 2014-02-04 18:51:25+11:00 Observation final Pain severity - Reported 7.3922 {score} Diagnosis Report History and physical note 2014-02-07 19:48:39+11:00 Observation final Pain severity - Reported 2.7768 {score} Diagnosis Report History and physical note 2014-02-10 20:45:21+11:00 Observation final Pain severity - Reported 5.0706 {score} Diagnosis Report History and physical note 2014-02-13 21:43:06+11:00 Observation final Pain severity - Reported 6.5288 {score} Diagnosis Report History and physical note 2014-02-16 22:28:36+11:00 Observation final Pain severity - Reported 7.9077 {score} Diagnosis Report History and physical note 2014-02-19 23:24:09+11:00 Observation final Pain severity - Reported 3.5263 {score} Diagnosis Report History and physical note 2014-02-23 00:22:43+11:00 Observation final Pain severity - Reported 4.0881 {score} Diagnosis Report History and physical note 2014-02-26 01:19:59+11:00 Observation final Pain severity - Reported 1.3286 {score} Diagnosis Report History and physical note 2014-03-01 02:18:13+11:00 Observation final Pain severity - Reported 9.0163 {score} Diagnosis Report History and physical note 2014-03-04 03:17:04+11:00 Condition Medication review due (situation) Condition Stress (finding) Observation final Body Height 180.4 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} Observation final Body Weight 97.9 kg Observation final Body mass index (BMI) [Ratio] 30.08 kg/m2 Observation final Blood pressure panel with all children optional 82 mm[Hg] 129 mm[Hg] Observation final Heart rate 79 /min Observation final Respiratory rate 14 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 155.69 mg/dL Observation final Triglycerides 147.12 mg/dL Observation final Low Density Lipoprotein Cholesterol 92.45 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 33.81 mg/dL Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Observation final Total score [DAST-10] 0 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2015-11-05T18:51:25+11:00 Immunization completed Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed 2015-11-05T18:51:25+11:00 Immunization completed Hep A, adult 2015-11-05T18:51:25+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2015-11-05 18:51:25+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2015-11-05 20:12:40+11:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2015-11-05 20:49:21+11:00 Diagnosis Report History and physical note 2015-11-05 18:51:25+11:00 Condition Hyperlipidemia Condition Not in labor force (finding) Condition Unhealthy alcohol drinking behavior (finding) Observation final Cholesterol [Mass/volume] in Serum or Plasma 263.72 mg/dL Observation final Triglycerides 391.85 mg/dL Observation final Low Density Lipoprotein Cholesterol 175.31 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 34.282 mg/dL Observation final Glucose [Mass/volume] in Blood 82.09 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 12.25 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.511 mg/dL Observation final Calcium [Mass/volume] in Blood 9.79 mg/dL Observation final Sodium [Moles/volume] in Blood 142.05 mmol/L Observation final Potassium [Moles/volume] in Blood 4.46 mmol/L Observation final Chloride [Moles/volume] in Blood 103.59 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 25.71 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 74.878 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.8756 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.2354 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.3953 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.78098 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 63.332 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 25.773 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30.999 U/L Observation final Body Height 180.4 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} Observation final Body Weight 97.9 kg Observation final Body mass index (BMI) [Ratio] 30.08 kg/m2 Observation final Blood pressure panel with all children optional 85 mm[Hg] 119 mm[Hg] Observation final Heart rate 90 /min Observation final Respiratory rate 13 /min Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 1 {score} Observation final Total score [HARK] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Observation final Total score [AUDIT-C] 6 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2017-11-09T18:51:25+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2017-11-09 18:51:25+11:00 Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2017-11-09 18:51:25+11:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2017-11-09 20:07:18+11:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2017-11-09 20:34:35+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2017-11-09 21:08:47+11:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2017-11-09 21:45:04+11:00 Diagnosis Report History and physical note 2017-11-09 18:51:25+11:00 Diagnosis Report History and physical note 2017-11-30 18:51:25+11:00 Condition Myocardial infarction (disorder) Condition Acute non-ST segment elevation myocardial infarction (disorder) Observation final Leukocytes [#/volume] in Blood by Automated count 3.3606 10*3/uL Observation final Erythrocytes [#/volume] in Blood by Automated count 4.6572 10*6/uL Observation final Hemoglobin [Mass/volume] in Blood 13.497 g/dL Observation final Hematocrit [Volume Fraction] of Blood by Automated count 40.924 % Observation final MCV [Entitic volume] by Automated count 90.582 fL Observation final MCH [Entitic mass] by Automated count 27.171 pg Observation final MCHC [Mass/volume] by Automated count 35.16 g/dL Observation final Erythrocyte distribution width [Ratio] by Automated count 13.138 % Observation final Platelets [#/volume] in Blood by Automated count 139.52 10*3/uL Observation final Glucose [Mass/volume] in Serum or Plasma 99.67 mg/dL Observation final Urea nitrogen [Mass/volume] in Serum or Plasma 9.92 mg/dL Observation final Creatinine [Mass/volume] in Serum or Plasma 2.5892 mg/dL Observation final Calcium [Mass/volume] in Serum or Plasma 8.86 mg/dL Observation final Sodium [Moles/volume] in Serum or Plasma 137 mmol/L Observation final Potassium [Moles/volume] in Serum or Plasma 4.58 mmol/L Observation final Chloride [Moles/volume] in Serum or Plasma 103.88 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Serum or Plasma 20.22 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 7.4028 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.4722 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.0478 g/dL Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 7.5029 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 83.633 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 0.95949 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 33.294 U/L Observation final Magnesium [Mass/volume] in Blood 2.1124 mg/dL Observation final Cholesterol [Mass/volume] in Serum or Plasma 247.2 mg/dL Observation final Triglycerides 121.33 mg/dL Observation final Low Density Lipoprotein Cholesterol 174.21 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 38.76 mg/dL Observation final Hemoglobin A1c/Hemoglobin.total in Blood 5.57 % Observation final INR in Platelet poor plasma by Coagulation assay 0.9488 {INR} Observation final aPTT in Blood by Coagulation assay 31.421 s Observation final Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Blood by Immunoassay 1.9777 pg/mL Observation final Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method 76.061 ng/L Observation final Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method 89.121 ng/L Medication 212033 aspirin 325 MG Oral Tablet active Medication 198039 nitroglycerin 0.4 MG Sublingual Tablet active Medication 1728805 2 ML morphine sulfate 1 MG/ML Injection active Diagnosis Report CBC panel - Blood by Automated count 2018-04-02 18:08:17+10:00 Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2018-04-02 18:08:17+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2018-04-02 18:08:17+10:00 Diagnosis Report History and physical note 2018-04-02 17:51:25+10:00 Condition History of myocardial infarction (situation) Medication 1361048 heparin sodium, porcine 100 UNT/ML Injectable Solution active Medication 749196 clopidogrel 300 MG Oral Tablet active Diagnosis Report History and physical note 2018-04-02 18:48:17+10:00 Observation final Glucose [Mass/volume] in Blood 67.57 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 13.25 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.221 mg/dL Observation final Calcium [Mass/volume] in Blood 8.7 mg/dL Observation final Sodium [Moles/volume] in Blood 137.25 mmol/L Observation final Potassium [Moles/volume] in Blood 3.85 mmol/L Observation final Chloride [Moles/volume] in Blood 107.11 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 28.13 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 80.365 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.8117 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 3.8016 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.1968 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.90141 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 49.475 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 52.166 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 39.75 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 172.44 mg/dL Observation final Triglycerides 122.76 mg/dL Observation final Low Density Lipoprotein Cholesterol 85.814 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 33.112 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2018-11-30 18:51:25+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2018-11-30 18:51:25+11:00 Diagnosis Report History and physical note 2018-11-30 18:51:25+11:00 Condition Full-time employment (finding) Observation final Body Height 180.4 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} Observation final Body Weight 97.9 kg Observation final Body mass index (BMI) [Ratio] 30.08 kg/m2 Observation final Blood pressure panel with all children optional 72 mm[Hg] 110 mm[Hg] Observation final Heart rate 74 /min Observation final Respiratory rate 14 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 154.2 mg/dL Observation final Triglycerides 144.12 mg/dL Observation final Low Density Lipoprotein Cholesterol 89.76 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 35.61 mg/dL Observation final Leukocytes [#/volume] in Blood by Automated count 4.2679 10*3/uL Observation final Erythrocytes [#/volume] in Blood by Automated count 4.9133 10*6/uL Observation final Hemoglobin [Mass/volume] in Blood 14.623 g/dL Observation final Hematocrit [Volume Fraction] of Blood by Automated count 47.74 % Observation final MCV [Entitic volume] by Automated count 94.857 fL Observation final MCH [Entitic mass] by Automated count 32.309 pg Observation final MCHC [Mass/volume] by Automated count 35.73 g/dL Observation final Erythrocyte distribution width [Entitic volume] by Automated count 39.814 fL Observation final Platelets [#/volume] in Blood by Automated count 394.05 10*3/uL Observation final Platelet distribution width [Entitic volume] in Blood by Automated count 352.61 fL Observation final Platelet mean volume [Entitic volume] in Blood by Automated count 10.28 fL Observation final Tobacco smoking status Observation final Total score [HARK] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 {score} Observation final Total score [AUDIT-C] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2019-11-14T18:51:25+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2019-11-14 18:51:25+11:00 Diagnosis Report CBC panel - Blood by Automated count 2019-11-14 18:51:25+11:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2019-11-14 20:06:35+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2019-11-14 20:45:57+11:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2019-11-14 21:29:35+11:00 Diagnosis Report History and physical note 2019-11-14 18:51:25+11:00 Condition Viral sinusitis (disorder) Diagnosis Report History and physical note 2019-11-21 18:51:25+11:00 Observation final Glucose [Mass/volume] in Blood 65.33 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 9.89 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.42 mg/dL Observation final Calcium [Mass/volume] in Blood 8.53 mg/dL Observation final Sodium [Moles/volume] in Blood 136.43 mmol/L Observation final Potassium [Moles/volume] in Blood 5.17 mmol/L Observation final Chloride [Moles/volume] in Blood 110.25 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 22.28 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 85.367 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.6344 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 4.6851 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.4297 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.23985 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 117.62 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 36.828 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 6.7286 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 197.58 mg/dL Observation final Triglycerides 129.98 mg/dL Observation final Low Density Lipoprotein Cholesterol 99.492 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 44.26 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2019-11-30 18:51:25+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2019-11-30 18:51:25+11:00 Diagnosis Report History and physical note 2019-11-30 18:51:25+11:00 Observation final Glucose [Mass/volume] in Blood 78.16 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 19.75 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.805 mg/dL Observation final Calcium [Mass/volume] in Blood 9.45 mg/dL Observation final Sodium [Moles/volume] in Blood 137.18 mmol/L Observation final Potassium [Moles/volume] in Blood 4.99 mmol/L Observation final Chloride [Moles/volume] in Blood 107.29 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 21.57 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 88.491 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.405 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 3.8569 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.1146 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.14175 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 129.53 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 35.253 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 13.196 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 207.84 mg/dL Observation final Triglycerides 171.19 mg/dL Observation final Low Density Lipoprotein Cholesterol 132.25 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 39.696 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2020-11-29 18:51:25+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2020-11-29 18:51:25+11:00 Diagnosis Report History and physical note 2020-11-29 18:51:25+11:00 Immunization completed SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 2021-08-19T17:51:25+10:00 Diagnosis Report History and physical note 2021-08-19 17:51:25+10:00 Immunization completed SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 2021-09-09T17:51:25+10:00 Diagnosis Report History and physical note 2021-09-09 17:51:25+10:00 Condition Part-time employment (finding) Observation final Body Height 180.4 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} Observation final Body Weight 97.9 kg Observation final Body mass index (BMI) [Ratio] 30.08 kg/m2 Observation final Blood pressure panel with all children optional 74 mm[Hg] 104 mm[Hg] Observation final Heart rate 70 /min Observation final Respiratory rate 16 /min Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 {score} Observation final Total score [DAST-10] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2021-11-18T18:51:25+11:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2021-11-18 20:14:36+11:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2021-11-18 20:50:30+11:00 Diagnosis Report History and physical note 2021-11-18 18:51:25+11:00 Observation final Glucose [Mass/volume] in Blood 90.2 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 7.88 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.3662 mg/dL Observation final Calcium [Mass/volume] in Blood 8.61 mg/dL Observation final Sodium [Moles/volume] in Blood 142.78 mmol/L Observation final Potassium [Moles/volume] in Blood 4.92 mmol/L Observation final Chloride [Moles/volume] in Blood 103.13 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 28.13 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 79.523 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.7674 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 4.8697 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.4314 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.45237 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 120.53 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22.949 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26.685 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 161.49 mg/dL Observation final Triglycerides 148.05 mg/dL Observation final Low Density Lipoprotein Cholesterol 146 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 43.42 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2021-11-29 18:51:25+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2021-11-29 18:51:25+11:00 Diagnosis Report History and physical note 2021-11-29 18:51:25+11:00 Observation final Glucose [Mass/volume] in Blood 98.84 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 8.99 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.0496 mg/dL Observation final Calcium [Mass/volume] in Blood 10.01 mg/dL Observation final Sodium [Moles/volume] in Blood 140.67 mmol/L Observation final Potassium [Moles/volume] in Blood 4.01 mmol/L Observation final Chloride [Moles/volume] in Blood 109.31 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 25.64 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 68.907 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.7201 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 3.8742 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.8628 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.8395 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 105.39 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 48.508 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 39.194 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 158.87 mg/dL Observation final Triglycerides 101.14 mg/dL Observation final Low Density Lipoprotein Cholesterol 134.52 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 46.218 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2022-11-29 18:51:25+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2022-11-29 18:51:25+11:00 Diagnosis Report History and physical note 2022-11-29 18:51:25+11:00